ArticleNature biotechnology2015
Modeling the course of amyotrophic lateral sclerosis.
Article in Nature biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.Journal of molecular neuroscience : MN · 2020Pooled it
- Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis.International journal of molecular sciences · 2023Article
- Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022Review
- A proportional-hazards model for survival analysis and long-term survivors modeling: application to amyotrophic lateral sclerosis data.Journal of applied statistics · 2022Article
- Exploiting mutual information for the imputation of static and dynamic mixed-type clinical data with an adaptive k-nearest neighbours approach.BMC medical informatics and decision making · 2020Article
- Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1Frontiers in neuroscience · 2019Article
- Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols.Frontiers in neurology · 2018Article
- Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction.Frontiers in neuroinformatics · 2018Article
- Complete hazard ranking to analyze right-censored data: An ALS survival study.PLoS computational biology · 2017Article
- Urinary p75Neurology · 2017Article
- Predicting disease progression in amyotrophic lateral sclerosis.Annals of clinical and translational neurology · 2016Article
- Erratum: Modeling the course of amyotrophic lateral sclerosis.Nature biotechnology · 2015Article
Corrections and comments
- Comment on
- Erratum issued
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25574636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.